[
    [
        {
            "time": "2019-12-31",
            "original_text": "沃森生物(300142.SZ)2019年度净利润预降85%-87% 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2019年度",
                    "净利润",
                    "预降",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)2019年度净利润预降85%-87% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "沃森生物：2019年业绩预减85%-87% 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2019年",
                    "业绩",
                    "预减",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：2019年业绩预减85%-87% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]